Allscripts (MDRX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Allscripts announces second quarter 2016 results
August 4, 2016 4:03 PM EDTAll-time record bookings of $362 million, 39 percent growth year-over-year GAAP revenue grows 10 percent and non-GAAP revenue grows 13 percent, year-over-yearOperating and free cash flow grow 85 and 76 percent year-over-year, respectively, in the quarter
CHICAGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2016.
Second Quarter Business Highlights      Â
OptumCare, part of Optum and UnitedHealth Group, signed a strategic 10-year agreement to deploy the Allscripts... More